Form 4: Eli Casdin Reports Acquisition of Standard BioTools Stock and Options
SEC Form 4
Eli Casdin, a director and 10% owner of Standard BioTools Inc., reported acquiring shares and options, along with adjustments to existing holdings through various funds.
Summary
- Eli Casdin, a director and significant shareholder of Standard BioTools Inc., filed a Form 4 detailing changes in beneficial ownership.
- On June 28, 2024, Casdin acquired 43,128 shares of common stock and 72,213 stock options.
- The stock options have an exercise price of $1.77 and become exercisable in monthly installments starting July 28, 2024, expiring on June 28, 2034.
- The filing also reflects adjustments to shares held indirectly through various funds managed by Casdin Capital, including Casdin Private Growth Equity Fund II, L.P., Casdin Private Growth Equity Fund, L.P., Casdin Partners Master Fund, L.P., and Casdin Amplify Fund, LP.
- Casdin disclaims beneficial ownership of these securities except to the extent of his pecuniary interest.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard regulatory filing detailing changes in ownership. The acquisition of shares and options could be interpreted as a slightly positive signal, but it's not definitive.
Positives
- Acquisition of shares and options by a director and significant shareholder can be seen as a positive signal, indicating confidence in the company's future prospects.
Future Outlook
The document does not contain specific forward-looking statements about the company's future performance.
Management Comments
- The Reporting Person disclaims beneficial ownership in the securities reported on this Form 4 except to the extent of his pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency regarding the trading activities of company insiders. This filing indicates changes in Eli Casdin's holdings in Standard BioTools, which may be of interest to investors monitoring insider sentiment.
Stakeholder Impact
- The changes in ownership may influence investor perception of Standard BioTools.
Key Dates
| Date | Description |
|---|---|
| 06/28/2024 | Date of transaction: acquisition of shares and stock options. |
| 06/28/2025 | Date of full vesting of Restricted Stock Units (RSUs), or one day prior to the next annual meeting of stockholders. |
| 07/28/2024 | Start date for monthly vesting of stock options. |
| 06/28/2034 | Expiration date of stock options. |
| 07/02/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.